INSIGHTS

Insights that cut through complexity

No One Really Knows How We’ll Pay for Gene Therapies

No One Really Knows How We’ll Pay for Gene Therapies

Gene therapies are here and they have the potential to be miraculous. And extremely expensive. The science behind these therapies…
COVID-19 Treatment Update

COVID-19 Treatment Update

The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and…
The Implications of Polypharmacy on the Payor and Patient

The Implications of Polypharmacy on the Payor and Patient

There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care…
2021 Q3 RemedyOne Quarterly Pipeline Report

2021 Q3 RemedyOne Quarterly Pipeline Report

Download our 2021 Q3  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy

Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy

For the first time in 18 years, the FDA has approved a drug to treat patients with Alzheimer’s disease. It’s…
Can the Vaccine Rollout Guide Us to More Efficient Health Care?

Can the Vaccine Rollout Guide Us to More Efficient Health Care?

What the Covid vaccine taught us, and how we can be better. See this article as it originally appeared in…
Effects of COVID-19 on Mental Health

Effects of COVID-19 on Mental Health

As the number of COVID-19 hospitalizations and deaths are trending downward and vaccines are currently showing efficacy in the U.S.,…
Hospital Price Transparency Rule Not Enough to Lower Drug Prices

Hospital Price Transparency Rule Not Enough to Lower Drug Prices

Our healthcare system is extremely complex and increasing drug pricing transparency will be a big part of simplifying it in…
2021 Q2 RemedyOne Quarterly Pipeline Report

2021 Q2 RemedyOne Quarterly Pipeline Report

Download our 2021 Q2  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Digital Health Trends: Digital Therapeutics

Digital Health Trends: Digital Therapeutics

Defining the Digital Health Landscape Digital health has been a trending topic for several years now. Using technology to improve…
The Latest on HIV Treatment

The Latest on HIV Treatment

History HIV treatment has come a long way since 1987 when the first breakthrough zidovudine, a failed cancer drug from…
The Most Favored Nation Model and Interim Final Rule – What is this?

The Most Favored Nation Model and Interim Final Rule – What is this?

The rising costs of physician-administered drugs covered under Medicare Part B is one of the largest drivers of Medicare spend…
“Alexa, refill my prescription!”

“Alexa, refill my prescription!”

Introducing: Amazon Pharmacy….. What this launch means for the $300 billion prescription drug market and the traditional pharmacy chains currently…
Don’t Let the Fox Guard Your Henhouse: 6 Questions to Ask Your Large National Broker

Don’t Let the Fox Guard Your Henhouse: 6 Questions to Ask Your Large National Broker

Pharmacy benefits are complex, seemingly on purpose. If you are with a large national broker and are utilizing their coalition…
COVID-19 Vaccine Update

COVID-19 Vaccine Update

COVID-19 has infected over 10 million people in the United States and has claimed the lives of over 237,000 people…
Cutting Through the Complexity of Biosimilars

Cutting Through the Complexity of Biosimilars

The biologic drug market is huge in the US and it continues to grow at a rapid pace. However, great…
Uncovering solutions for affordable drug pricing

Uncovering solutions for affordable drug pricing

The House Committee on Oversight and Reform held a series of hearings to review findings from an in-depth investigation into…
RemedyOne Drug Spotlight: Rukobia

RemedyOne Drug Spotlight: Rukobia

Rukobia (fostemasavir) There are an estimated 2 million people living with the human immunodeficiency virus (HIV) in the United States.…
CMS’s Proposed Prescription Drug Value-Based Purchasing Rule

CMS’s Proposed Prescription Drug Value-Based Purchasing Rule

Paving the Way for Payment Innovation On June 17, 2020, CMS announced a proposed rule that would change how pharmaceutical manufacturers…
Albuterol 101 plus…

Albuterol 101 plus…

Albuterol is a short acting beta agonist (SABA) used to treat or prevent bronchospasm in patients with reversible obstructive airway…
Acute Migraine Treatments – What’s New?

Acute Migraine Treatments – What’s New?

Migraine is a neurological disorder with severe throbbing/pulsating headache generally associated with visual disturbances, nausea, vomiting, dizziness, and sensitivity to…
Gene Therapy – It’s here, are you ready?

Gene Therapy – It’s here, are you ready?

Thanks to advances in modern medicine, diseases caused by genetic disorders such as spinal muscular atrophy and retinal defects can…
Pandemic Response Update—Insights Into the Cycle

Pandemic Response Update—Insights Into the Cycle

As the COVID-19 Pandemic continues to sweep across the US, it seems there are new updates on the healthcare front…
Navigating the Complex World of Generics and Authorized Generics

Navigating the Complex World of Generics and Authorized Generics

Executive Summary Today, generics are widely available and more regulated, with improved quality compared to that of the not-so-distant past.…
What’s Really Going on with Drug Prices?

What’s Really Going on with Drug Prices?

Are prices up? Down? Staying the Same? The answer depends on who you listen to and when. In an atmosphere…
Like what you’re seeing? Get more Insights sent to you.
  • This field is for validation purposes and should be left unchanged.